Printer Friendly
The Free Library
23,389,518 articles and books


Two of the World's Top Geneticists Are Coming to Miami.

MIAMI -- Two of the most acclaimed geneticists in the world, Dr. Margaret Pericak-Vance and Dr. Jeffery Vance of Duke University, are bringing their pioneering research into the genetics of a multitude of diseases to Miami.

The Vances' Center for Human Genetics at Duke has uncovered critical clues to the origins of diseases including Parkinson's, Alzheimer's, age-related macular degeneration, multiple sclerosis, autism and the muscular dystrophies. At the University of Miami Miller School of Medicine, they will lead a team of investigators that will make up a new Institute of Human Genomics and a proposed Department of Human Genetics.

"The state of Florida is making substantial strides in recruiting some of the very best scientific institutes and centers to our region," said Pascal J. Goldschmidt, M.D., senior vice president for medical affairs and dean of the Miller School. "A paradigm for this remarkable opportunity for the citizens of Florida is the recruitment of the Center for Human Genetics, led by Margaret and Jeff Vance."

Margaret Pericak-Vance, Ph.D., is director of Duke's Center for Human Genetics, James B. Duke Professor of Medicine, and Chief of the Section of Medical Genetics at Duke University Medical Center. Her groundbreaking use of novel disease gene mapping led in 1993 to the identification of the major susceptibility gene for Alzheimer's disease - apolipoprotein E - and very recently to the discovery of a gene that determines risk for developing age-related macular degeneration.

Jeffery Vance, Ph.D., M.D., is the associate director of the Duke Center for Human Genetics, professor of medicine, and director of the Morris K. Udall Parkinson Disease Research Center of Excellence at Duke. His lab has found and studied genes that contribute to diseases including Parkinson's, Alzheimer's, cardiovascular disease, and one of the most common inherited neurological disorders, Charcot-Marie-Tooth Disease.

"Jeff and I love to build things, we love to be creative when we build things, and we like to think outside the box," Pericak-Vance said. "This is the opportunity to build something truly outstanding and to integrate all of the University of Miami's strengths into one program.

"Genomic medicine is going to change the way we practice medicine from being reactive to being proactive," she said. "We will discover ways to prevent disease, and we will find better treatments that are based on understanding the complex causes underlying the disorders.

"We have the power now to sort this out and to look at the whole picture."

UM President Donna E. Shalala said the Vances "Lead the field of human genetics, particularly as it relates to the common illnesses that all of us are exposed to - neurological disorders, heart disease, cancer, vision impairment. In Miami they will lead one of the premier institutes for human genomics in the world."

The Duke team includes several other investigators who will also be moving to South Florida. "We're a very integrated group, we're multidisciplinary, and we work together on a daily basis," Jeffery Vance said. "Miami is just a tremendous opportunity to continue to grow, and to begin to translate some of these genes that we're finding into actual practice. That's the ultimate goal.

"The University has two of the best academic leaders in the country: Pascal Goldschmidt and Donna Shalala," he added. "And there are some terrific researchers - in diabetes, spinal cord injury, cancer, eye disease, autism, and many other areas - who present real opportunities for collaboration."

Dean Goldschmidt said the Miami genomics institute "Will create a formidable opportunity to apply the new knowledge brought out by the Human Genome Project and translate this knowledge into findings that will help our patients survive some of the most deadly diseases."

"They will bring this opportunity not only to all of us at the University of Miami Miller School of Medicine, but also to everyone involved in biomedical research in South Florida, including Florida International University, Florida Atlantic University, the Scripps Research Institute and many other groups."
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 31, 2006
Words:651
Previous Article:Wired Digital Acquires Reddit.com.
Next Article:Bentley Pharmaceuticals to Present at the Rodman & Renshaw 8th Annual Healthcare Conference.
Topics:



Related Articles
Sequencing the genome: crusade called off.
The ticcing link: many mental disorders and a few crucial genes may tie into Tourette's syndrome.
Mutant monikers: a tale of freaky flies and gonzo geneticists.
Artificial chromosomes: just add genes.
Gene pair may incite obesity, depression.
Human Genome Work Reaches Milestone.
NATURE MEETS NURTURE BEHAVIOR PROBLEMS NOT AS SIMPLE AS XYY, SCIENTISTS ARE LEARNING.
Founding families: New World was settled by small tribe.
Autism's DNA trail: gene variant tied to developmental disorder.
Genetic basis of UVB sensitivity.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters